ASIís Immunosuppressive Proficiency Testing Scheme transferred to LGC

ABOUT US
DOWNLOAD OUR BROCHURE
OUR SERVICES
CONTACT DETAILS
We are delighted to announce that LGC has acquired the ASI world-leading
Immunosuppressive Proficiency Testing (PT) Scheme.
LGC has an extensive portfolio of PT schemes and the ASI Immunosuppressive Scheme will complement well their existing clinical PT portfolio.

LGC already has in depth experience of our Scheme, having produced and distributed test samples used in the Scheme for the last 6 years. Prof. David Holt, one of the Scheme founders, will remain closely associated with its onward running and development.

For the remainder of 2016, the Scheme will operate as normal. During 2017 the Scheme will be added to LGCís online PT system, providing you access to the range of features that this on-line system brings. Furthermore you will benefit from LGCís global capability and experience in running international PT schemes.

LGC will shortly send you details for registering for 2017.

In the mean time please do not hesitate to contact us (ipt2017@bioanalytics.co.uk)
should you have any queries.